Alphabet’s Isomorphic Labs in Funding Talks for At Least $40 Billion Value
Deals·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.’s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort.
The funding discussions indicate strong investor interest in the biotech sector, particularly in companies leveraging artificial intelligence for drug discovery.
Alphabet
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.’s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort.”
Bloomberg — Alphabet’s Isomorphic Labs in Funding Talks for at Least $40 Billion Value